Several clinical trials in individuals with type 2 diabetes show that high doses of a-LA improve glucose utilization, improve insulin sensitivity and lower fasting blood glucose and insulin concentrations [8,9,10,11,12,13]. The gene discussed is INS; the disease is type 2 diabetes mellitus.